A Novel Hybrid Nano-composite Grafted Electrochemically Reduced Graphene Oxide Based Sensor for Sensitive Determination of Efavirenz

Insights into the Design of An Enzyme Free Sustainable Sensing Platform for Efavirenz

In this study, a new hybrid sensor was developed using titanium oxide nanoparticles (TiO2-NPs) and nafion as an anchor agent on a glassy carbon electrode (GCE/TiO2-NPs-nafion) to detect efavirenz (EFV), an anti-HIV medication. TiO2-NPs was synthesized using Eucalyptus globulus leaf extract and characterized using ultraviolet–visible spectroscopy (UV–VIS), scanning electron microscopy (SEM), X-ray diffraction (XRD), and energy-dispersive spectroscopy (EDS). The electrochemical and sensing properties of the developed sensor for EFV were assessed using cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). The current response of GCE/TiO2-NPs-nafion electrode towards the oxidation of EFV was greater compared to the bare GCE and GCE/TiO2-NPs electrodes. A linear dynamic range of 4.5 to 18.7 µM with 0.01 µM limit of detection was recorded on the electrode using differential pulse voltammetry (DPV). The electrochemical sensor demonstrated good selectivity and practicality for detecting EFV in pharmaceuticals (EFV drugs) with excellent recovery rates, ranging from 92.0–103.9%. The reactive sites of EFV have been analyzed using quantum chemical calculations based on density functional theory (DFT). Monte Carlo (MC) simulations revealed a strong electrostatic interaction on the substrate-adsorbate (GCE/TiO2-NPs-nafion-EFV) system. Results show good agreement between the MC computed adsorption energies and the experimental CV results for EFV. The stronger adsorption energy of nafion onto the GCE/TiO2-NPs substrate contributed to the catalytic role in the signal amplification for sensing of EFV. Our results provide an effective way to explore the design of new 2D materials for sensing of EFV, which is highly significant in medicinal and materials chemistry.

Analytical Methods for Determination of Antiviral Drugs in Different Matrices: Recent Advances and Trends

Viruses are the main pathogenic substances that cause severe diseases in humans and other living things. They are among the most common microorganisms, and consequently, antiviral drugs have emerged to prevent and treat viral infections. Antiviral drugs are an essential drug group considering their prescription and consumption rates for different diseases and indications. Therefore, it is crucial to develop accurate and precise analytical methods to detect antiviral drugs in various matrices. Chromatographic techniques are used frequently for the quantification purpose since they allow simultaneous determination of antivirals. Electrochemical methods have also gained importance since the analysis can be performed quickly without the need for pretreatment. Spectrophotometric and spectrofluorimetric methods are used because they are simple, inexpensive, and less time-consuming methods. The purpose of this review is to present an overview of the analysis of currently used antiviral drugs from 2010 to 2021. Since studies on antiviral drugs are numerous, selected publications were reviewed in this article. The analysis of antiviral drugs was divided into three main groups: chromatographic, spectrometric, and electrochemical methods which were applied to different matrices, including pharmaceutical, biological, and environmental samples.

A Concise Analytical Profile of Efavirenz: Analytical Methodologies

Non-nucleoside reverse transcriptase inhibitors are the prime members of antiretroviral therapy that are presently employed for the management of the human immunodeficiency virus. It uses an enzyme i.e., reverse transcriptase to convert its ribonucleic acid into reverse transcription; these agents impede the function of reverse transcriptase and reverse transcription counter human immunodeficiency virus from replicating. Efavirenz is the first-generation non-nucleoside reverse transcriptase inhibitor agent. Similar to the other non-nucleoside reverse transcriptase inhibitor agents; it is prescribed with other inhibitors in combination for regimens antiretroviral therapy. To enhance survival and avoid aggressive infections in patients affected with human immunodeficiency virus infection, adequate antiretroviral therapy is the most significant treatment. Accordingly, the development and validation of such therapeutic agents are challenging work for the analysts. Therefore, the proposed review integrally addresses the analytical reports of efavirenz recorded in the literature databases like Scopus, Web of Science, Google Scholar, Pub-Med, and through many other sources. It has been remarked that for the development of efavirenz many analytical techniques were used for addressing the qualitative and quantitative estimation of efavirenz from various pharmaceutical and biological matrices. This review plan to review the stereochemistry, mechanism of action, resistance, pharmacokinetics, pharmacodynamics, safety and adverse reaction, and various analytical approaches assessed for the same. The hyphenated and chromatographic techniques are frequently used for analysis of cited drug.